Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV. [electronic resource]
Producer: 20150529Description: 1159-65 p. digitalISSN:- 1815-7920
- Algorithms
- Antitubercular Agents -- therapeutic use
- CD4 Lymphocyte Count
- Cost-Benefit Analysis
- Drug Resistance, Bacterial
- HIV Infections -- drug therapy
- Humans
- Isoniazid -- therapeutic use
- Models, Economic
- Mycobacterium tuberculosis -- drug effects
- Radiography
- Rifampin -- therapeutic use
- Sensitivity and Specificity
- Tuberculosis -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.